Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul;26(1):67-71.

Molecular genetics of late onset glycogen storage disease II in Italy

Affiliations

Molecular genetics of late onset glycogen storage disease II in Italy

M G Pittis et al. Acta Myol. 2007 Jul.

Abstract

Glycogen Storage Disease Type II (GSDII) is a recessively inherited disorder due to the deficiency of acid alpha-glucosidase (GAA) that results in glycogen accumulation in the lysosomes. The molecular analysis of the GAA gene was performed on 45 Italian patients with late onset GSDII. DHPLC analysis revealed 28 polymorphisms spread all over the GAA gene. Direct sequencing identified the 96% of the mutant alleles, 12 of which are novel. Missense mutations were functionally characterized by enzyme activity and protein processing in a human GAA deficient cell line while splicing mutations were studied by RT-PCR and in silico analysis. A complex allele was also identified carrying three different alterations in cis. All the patients studied carried a severe mutation in combination with a milder one, which explains the late onset of the disease. The c.-32-13T > G was the most frequent mutation, present as compound heterozygote in 85% of the patients as described in other late onset GSDII Caucasian populations. Interestingly, 10 of the 45 patients carried the c.-32-13T > G associated to the severe c.2237G > A (p.W746X) mutation. However, despite the common genotype, patients presented with a wide variability in residual enzyme activity, age of appearance of clinical signs and rate of disease progression, suggesting that other genetic/environment factors may modulate clinical presentation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A) Enzyme activity in GAA deficient fibroblasts transiently transfected with the wild type pCDNA3-GAA and mutant constructs, measured using the fluorogenic substrate 4-MU-a-D-glucopyranoside. B) Western blot analysis of the cellular extracts described above All GAA forms are detected in the wild type transfected cells (WT) while no GAA is detected in the mock transfected cells (ALDP). Almost all the protein obtained from the c.1465G > A and c.1836C > G constructs remained as the GAA inactive precursor of 110kD. The c.1645G > A mutant was correctly processed while c.1645G > C accumulates predominantly as the 110kD and 76kD forms. For the c.1333G > C construct, a faint band of 110 kD was detected when a higher amount of protein was loaded onto the gel, suggesting that the protein is highly unstable and it is rapidly degraded.
Figure 1
Figure 1
A) Enzyme activity in GAA deficient fibroblasts transiently transfected with the wild type pCDNA3-GAA and mutant constructs, measured using the fluorogenic substrate 4-MU-a-D-glucopyranoside. B) Western blot analysis of the cellular extracts described above All GAA forms are detected in the wild type transfected cells (WT) while no GAA is detected in the mock transfected cells (ALDP). Almost all the protein obtained from the c.1465G > A and c.1836C > G constructs remained as the GAA inactive precursor of 110kD. The c.1645G > A mutant was correctly processed while c.1645G > C accumulates predominantly as the 110kD and 76kD forms. For the c.1333G > C construct, a faint band of 110 kD was detected when a higher amount of protein was loaded onto the gel, suggesting that the protein is highly unstable and it is rapidly degraded.

Similar articles

Cited by

References

    1. Hirschhorn R, Reuser AJJ. Glycogen storage disease type II: acid α-glucosidase (acid maltase) deficiency, In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. Vol 3, 8th edn. New York: McGraw-Hill; 2001. p. 3389-420.
    1. Raben N, Plotz P, Byrne BJ. Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med 2002;2:145-66. - PubMed
    1. Van den Hout HM, Hop W, van Diggelen OP. The natural course of infantile Pompe’s disease: 20 original cases compared with 133 cases from the literature. Pediatrics 2003;112:332-40. - PubMed
    1. Kishnani PS, Howell RR. Pompe disease in infants and children. J Pediatr 2004;144:35-43. - PubMed
    1. Slonim AE, Bulone L, Ritz S, Goldberg T, Chen A, Martiniuk F. Identification of two subtypes of infantile acid maltase deficiency. J Pediatr 2000;137:283-5. - PubMed

Associated data

LinkOut - more resources